EMEA-002873-PIP01-20 - paediatric investigation plan

Live-attenuated La Reunion strain of chikungunya virus (VLA1553)

Key facts

• Active Substance:
  Live-attenuated La Reunion strain of chikungunya virus (VLA1553)
• Therapeutic area:
  Vaccines
• Decision number:
  P/0501/2023
• PIP number:
  EMEA-002873-PIP01-20
• Pharmaceutical form(s):
  Powder and solvent for suspension for injection
• Condition(s) / indication(s):
  Prevention of chikungunya disease
• Route(s) of administration:
  Intramuscular use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  24/11/2023

Decision

P/0501/2023: EMA decision of 24 November 2023 on the acceptance of a modification of an agreed paediatric investigation plan for live-attenuated La Reunion strain of chikungunya virus (VLA1553) (EMEA-002873-PIP01-20-M01)

AdoptedReference Number: EMA/533540/2023